✨ Your Portfolio is fetched and updated from zerodha.
Market Cap
₹21,350 Cr.
P/E
34.55
  • Pfizer
  • Wockhardt
  • Alembic Pharma
  • TJI Pharma
FAQs on Pfizer Ltd. Shareprice

Pfizer has given lower returns compared to its competitors.
Pfizer has grown at ~-2.51% over the last 4yrs while peers have grown at a median rate of 11.34%

Pfizer is expensive when considering the EV/EBIDTA, however latest PE is < 3 yr avg PE.
Latest PE of Pfizer is 34.55, while 3 year average PE is 38.24.
Also latest EV/EBITDA of Pfizer is 26.91 while 3yr average is 26.88.

Growth Table
  • Pfizer Ltd.
  • Wockhardt
  • Alembic Pharma
Balance Sheet
  • Pfizer Ltd.
  • Wockhardt
  • Alembic Pharma
Balance Sheet Snapshot
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
*Data is as of latest FY end
Profit & Loss
  • Pfizer Ltd.
  • Wockhardt
  • Alembic Pharma
Cash Flow
  • Pfizer Ltd.
  • Wockhardt
  • Alembic Pharma
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
Ratios
= Dominant Factor
  • Pfizer Ltd.
  • Wockhardt
  • Alembic Pharma
Quarterly Results
  • Pfizer Ltd.
  • Wockhardt
  • Alembic Pharma
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
FAQs on Pfizer Ltd. Financials

Balance sheet of Pfizer is strong.
It shouldn't have solvency or liquidity issues.

Yes, The debt of Pfizer is increasing.
Latest debt of Pfizer is -₹2,278.82 Crs as of Sep-24.
This is greater than Mar-24 when it was -₹4,085.28 Crs.

The profit is oscillating.
The profit of Pfizer is ₹618 Crs for TTM, ₹551 Crs for Mar 2024 and ₹624 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Pfizer latest dividend payout ratio is 29.04% and 3yr average dividend payout ratio is 34.26%

Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments

Data feed provided by Accord Fintech